Vascular Endothelial Growth Factor (VEGF) as a Biomarker for Cancer-Associated Venous Thrombosis: A Meta-analysis
Cancer-associated thrombosis affects between 1 and 20% of all patients diagnosed with cancer and is associated with significant morbidity and a poorer prognosis. Risk assessment scores exist which include the measurement of biomarkers, and which aim to identify patients at a higher risk of developin...
Saved in:
Main Authors: | Alison M. Brown, Sophie Nock, Kathryn Musgrave, Amanda J. Unsworth |
---|---|
Format: | Article |
Language: | English |
Published: |
Georg Thieme Verlag KG
2025-01-01
|
Series: | TH Open |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/a-2513-4381 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Portal-splenic-mesenteric venous thrombosis in COVID-19 patients: a systematic review
by: Ricardo Zanetti Gomes, et al.
Published: (2025-02-01) -
Key prognostic risk factors linked to poor functional outcomes in cerebral venous sinus thrombosis: a systematic review and meta-analysis
by: Lili Lin, et al.
Published: (2025-02-01) -
Vascular endothelial growth factor A: friend or foe in the pathogenesis of HIV and SARS-CoV-2 infections?
by: Mieke A. van der Mescht, et al.
Published: (2025-02-01) -
Machine learning assisted radiomics in predicting postoperative occurrence of deep venous thrombosis in patients with gastric cancer
by: Yuan Zeng, et al.
Published: (2025-02-01) -
Recurrent venous thrombosis – an unusual first presentation of autoimmune polyendocrinopathy syndrome type 3B
by: N Letete, et al.
Published: (2023-12-01)